Tag: Covid

Categories
Politics

Home Democrats intention to go $1.9 trillion Covid reduction invoice on Friday

House Democrats aim to pass $1.9 trillion Covid relief bill on Friday

House Speaker Nancy Pelosi (D-CA) meets with fellow members of Congress to observe a moment of silence on the steps of the U.S. Capitol on February 23, 2021 in Washington, DC.

Al Drago | Getty Images

House Democrats plan to pass their $ 1.9 trillion coronavirus alleviation bill on Friday as lawmakers seek to prevent the unemployment lifeline from draining next month.

“The American people strongly support this bill and we are working swiftly to get it into force,” said Steny Hoyer, majority chairman, D-Md., In a statement posted on Twitter Tuesday evening.

The package includes $ 1,400 in direct payments to most Americans, a weekly unemployment benefit supplement of $ 400, and an expansion of the programs that allow millions more Americans to be eligible for unemployment insurance. It also spends $ 20 billion on Covid-19 vaccinations, $ 50 billion on testing, and $ 350 billion on state, local, and tribal government efforts.

The plan is to raise the federal minimum wage to $ 15 an hour by 2025. The determination cannot survive in the final calculation.

The Democrats have sought to get the legislation through budget vote themselves, which requires a simple majority in a Senate that is 50-50 split by party. They have argued that they can’t wait to ease economic troubles as they try to strike a deal with the GOP.

Republicans have questioned the need for nearly $ 2 trillion more as they point to vaccinations that will put the country on the path to a broader reopening.

“Much of that bill is a waste or wish-list for the progressives,” claimed Kevin McCarthy, minority chairman of the House of Representatives, R-Calif., During a CNBC “Squawk Box” interview Wednesday morning.

Democrats pushed for another bailout as the US stepped up vaccination efforts. More than 44 million people have now received one dose, and nearly 20 million had two, according to the Centers for Disease Control and Prevention.

While the country has made progress in building immunity, it still has around 71,500 Covid-19 cases and more than 2,000 deaths per day, according to a 7-day average calculated by CNBC using data from Johns Hopkins University. More than 500,000 Americans have now died from the disease.

With much of the country in place with economic restrictions to prevent infection, more than 18 million people received unemployment benefits earlier this month. More than 150 CEOs in New York on Wednesday pushed for the relief plan to be passed, saying “more needs to be done to put the country on a path to a strong and lasting recovery.”

The Democrats will next take the formal step to get the bill through the House Rules Committee and into the full chamber on Friday morning. The party leaders want to send the legislation to the Senate later that day.

Senate Majority Leader Chuck Schumer, DN.Y., has predicted that the Senate will approve the bill and send it to President Joe Biden before March 14. Programs to increase unemployment by $ 300 a week, expand insurance to gig workers and self-employed people, and increase the number of benefit weeks formally expire on date.

Schumer said Tuesday he wanted to keep his caucus together because Sens. Joe Manchin, DW.Va., and Kyrsten Sinema, D-Ariz., Oppose a minimum wage of $ 15 an hour. A single democratic vote against the law would sink it.

“I pitched our entire caucus today and I said we have to get this bill passed, the American people, the American public are calling for it,” Schumer said. He later held up his flip phone when asked how he manages an evenly divided Senate.

The Senate MP is expected to decide this week whether Congress can pass a minimum wage increase as part of the budget reconciliation.

Subscribe to CNBC on YouTube.

Categories
Health

Biden Covid staff holds briefing as U.S. demise toll reaches grim milestone

Biden Covid team holds briefing as U.S. death toll reaches grim milestone

[The stream is slated to start at 3 p.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden’s Covid-19 Response Team is holding a press conference Monday on the coronavirus pandemic that killed nearly 500,000 Americans, according to Johns Hopkins University.

Earlier in the day, White House Press Secretary Jen Psaki said Biden would order that all flags on federal properties be lowered to half the staff for the next five days to mark the grim milestone of 500,000 American deaths from Covid-19 .

Regardless, the Chief Medical Officer of the White House, Dr. Anthony Fauci, Americans, fight back a sense of Covid-19 complacency even as coronavirus infections are falling and some scientists predict herd immunity is just around the corner.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

U.S. Covid vaccine provide to considerably improve in March, drugmakers inform Congress

U.S. Covid vaccine supply to substantially increase in March, drugmakers tell Congress

Lillie McCray (R) receives Pfizer BioNTech’s Coronavirus Disease (COVID-19) vaccine from Walgreens Doctor Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois on February 22, 2021.

Kamil Krzaczynski | Reuters

The supply of Covid-19 vaccines in the US is expected to increase significantly next month as manufacturers double the production pace, company executives said in prepared remarks to be delivered to Congress on Tuesday.

Pfizer expects to ship more than 13 million doses of its two-shot vaccine per week to the US by mid-March, more than double the weekly number of doses the company shipped earlier this month, said John Young, chief Pfizer business officer, writing testimonial. The testimony was released prior to a hearing before the House Committee on Energy and Trade.

Young also said Pfizer is on track to dispense 120 million doses by the end of March, and another 80 million doses are expected to expire by the end of May.

The President of Moderna, Dr. Stephen Hoge said his company is similarly working to double its shipments to the US by April, according to the testimony prepared by Hoge. Moderna hopes to ship 40 million cans a month, which is roughly double the pace, he said.

“We have doubled our monthly shipments to the US government since late 2020 and are working to double them again to more than 40 million cans per month by April,” said Hoge. “As we work to achieve these goals, we are continuously learning and working closely with our partners and the federal government to find ways to remove bottlenecks and speed up our production.”

He added in the document that if the Food and Drug Administration authorizes the company to put more vaccine doses in each vial, it would “improve performance”.

U.S. supplies are also expected to be supported by new manufacturers entering the fray. The FDA is expected to review Johnson & Johnson’s one-shot vaccine on Thursday. J&J Vice President for Medical Affairs, Dr. Richard Nettles, said in his prepared testimony that the company plans to ship more than 20 million cans in the US by the end of March.

Nettles added that the company is confident of delivering 100 million cans in the first half of the year.

Taken together, the remarks suggest the US is on track to have received 240 million doses of vaccine by the end of March, enough to vaccinate about 130 million people.

That could be a huge boon to the vaccine launch. State and local officials said the biggest restriction was the delivery of cans by the federal government. According to the Centers for Disease Control and Prevention, more than 75.2 million doses have been given to states, and over 64.1 million doses have been given.

The House hearing is scheduled to begin at 10:30 a.m. ET.

Categories
Health

Cuba’s Covid vaccine may very well be made eligible for vacationers

Cuba's Covid vaccine could be made eligible for tourists

On October 23, 2020, at the Melia Varadero International Hotel in Matanzas Province, a man is standing near a Cuban national flag. Varadero, Cuba’s main seaside resort, is reopening to international tourism amid the coronavirus pandemic.

YAMIL LOCATION | AFP | Getty Images

Cuba’s most advanced Covid-19 vaccine candidate is set to enter late-stage clinical trials next week, bringing the tiny island nation ever closer to an exceptional medical performance that analysts believe will have far-reaching ramifications across the global south.

Cuba’s most promising vaccine candidate of the four under development is Soberana 02. The vaccine name translates from Spanish to “Sovereign”, an alleged allusion to Cuba’s national pride in its world-famous healthcare system.

Soberana 02 is scheduled to enter phase 3 studies from March 1. According to official figures, up to 150,000 volunteers will take part in the tests within weeks. Phase 3 trials represent the final phase before a vaccine is generally approved by national regulatory authorities.

It comes at a time when many people in Cuba are forced to stand in line for hours to buy basic goods and the authorities continue to adhere to a decade-long US trade embargo – with sanctions that former President Donald Trump has in recent years Years.

“It’s just this incredible dichotomy,” Helen Yaffe, a Cuba expert and lecturer in economic and social history at the University of Glasgow, Scotland, told CNBC over the phone.

“On one hand, you have this high-tech biotech sector that brings a lot of hope to the global south because there is the possibility of an affordable vaccine – (and) vaccinating the global south will be the priority,” said Yaffe.

“And at the same time, Cubans get up at four or five in the morning to join the queue because there is a real shortage of really basic food and even medicine.”

What do we know about Soberana 02?

The Cuban Finlay Institute, the country’s leading biopharma institution, is overseeing the development of Soberana 02. Vicente Verez, director of the institute, has indicated that the vaccine could be available as an option to tourists later this year.

If Soberana 02 is found to be safe and effective, the development of a domestically manufactured vaccine will likely be hailed as an astounding scientific breakthrough and major political triumph. Cuba would also be the first Latin American country to immunize its population with a domestically manufactured vaccine.

Technician Mayelin Mejias will work in the vaccine aseptic and packaging processing facility at the Finlay Vaccine Institute in Havana on January 20, 2021.

YAMIL LOCATION | AFP | Getty Images

The government has not yet outlined any concrete plans for vaccinating tourists, but analysts say it is possible for foreigners traveling to Cuba to receive their first dose of vaccine on the island before subsequent doses to take away.

Although public data are limited, it is believed that up to three doses of the vaccine could be given at two-week intervals.

People are already talking about sun, sea, sand and Soberana 02. So I wouldn’t be surprised if people went to Cuba to look for the vaccine and I’m sure the Cubans will offer it.

Helen Yaffe

Lecturer in Economic and Social History at the University of Glasgow

Yaffe, who is also the author of We Are Cuba !: How a Revolutionary People Survived in a Post-Soviet World, said Cuba’s sophisticated health system would help the country introduce the vaccine “extremely” quickly.

“I can guarantee that. And if they have a vaccine every two weeks, people could be vaccinated within a month of starting,” Yaffe said.

“By the summer, people will be pretty desperate to go on vacation, and I think Cuba, which is nominating itself as the ideal travel destination. People are already talking about sun, sea, sand and Soberana 02. So I wouldn’t be surprised if Die People go to Cuba to find the vaccine and I’m sure the Cubans will offer it. “

How does it work?

The Soberana 02 vaccine is a conjugated vaccine. This is a type of vaccine that contains a portion of the spike protein that binds or conjugates to human cells to increase its stability and effectiveness.

Unlike other coronavirus vaccine candidates like Pfizer-BioNTech, Soberana 02 doesn’t require any additional cooling requirements. This should ease the logistical and administrative challenges associated with vaccination programs in low-income countries.

People line up in Havana to buy groceries on Feb.2, 2021 as Covid-19 cases emerge in the island nation.

YAMIL LOCATION | AFP | Getty Images

At a virtual session led by the Pan American Health Organization on February 5, Dr. Verez, Soberana 02 returned “encouraging results” in the early test phases. He added that the vaccination has not yet produced any significant side effects.

The Cuban government has announced that it will produce 100 million cans of Soberana 02 this year to meet the needs of its own citizens as well as those in other countries. It is said to be one of the first countries in the world to vaccinate its entire population in 2021, though many advanced nations started administering bumps almost two months ago.

Several countries have expressed an interest in purchasing the vaccine, including Vietnam, Iran, Venezuela and the African Union, which represents all 55 countries in Africa.

Cuba, which has seen relatively few Covid cases compared to other countries in the region, has seen a sharp rise in infections and deaths in recent weeks. To date, Cuba has recorded 45,361 cases of the coronavirus and 300 deaths, according to Johns Hopkins University.

“One of the world’s best kept secrets”

Cuba has long been known for its medical diplomacy. Thousands of professionals have been sent abroad to help countries cope with short-term crises, natural disasters and medical emergencies.

Human rights groups have raised concerns that the Cuban government is imposing repressive rules on doctors working abroad and invoking the right to privacy, freedom, expression and association.

At the start of the Covid-19 outbreak, Cuba had an estimated 24,500 medical workers in 58 countries. Another 4,000 members of the Cuban Henry Reeve Brigade, a group of highly respected health professionals, have worked in countries from Kuwait to Mexico, Italy to South Africa.

Cuban doctors during a welcoming ceremony for Cuban health workers deployed in Cape Town, South Africa, in the Western Cape on May 24, 2020 to support efforts in the fight against COVID-19.

Mischa Jordaan | Gallo Images via Getty Images

It’s a deeply rooted tradition that the country, with just over 11 million, has more medical staff working overseas than all of the G7 countries combined.

“This is an extraordinary recording, largely unknown to the mainstream media – one of the best-kept secrets in the world,” said John Kirk, a professor in the Latin America program at Dalhousie University in Nova Scotia, Canada, via email to CNBC.

“Medical internationalism is in Cuban DNA, and the preamble to the Cuban Constitution mentions the obligation that Cuba must share its medical talent with developing countries,” he added.

Categories
Health

U.S. Reaches 500,000 Covid Deaths

U.S. Reaches 500,000 Covid Deaths

The virus has reached every corner of America, destroying dense cities and counties alike, with waves flowing through one region and then another.

In New York City, more than 28,000 people have died from the virus – or about one in 295 people. In Los Angeles County, the toll is roughly one in every 500 people. In Lamb County, Texas, where 13,000 people live in an area of ​​1,000 square miles, the loss is one in 163 people.

The virus has ravaged nursing homes and other long-term care facilities and spread easily among vulnerable residents: it causes more than 163,000 deaths, about a third of the country’s total.

Virus deaths have also disproportionately affected Americans across racial boundaries. Overall, the death rate for black Americans with Covid-19 was almost twice that of white Americans, according to the Centers for Disease Control and Prevention. The death rate for Hispanics was 2.3 times higher than for white Americans. And for Indians it was 2.4 times higher.

As of Monday, an average of 1,900 Covid deaths had been reported on most days – after more than 3,300 peak points in January. The slowdown was a relief, but scientists said variants made it difficult to project the future of the pandemic, and historians cautioned against turning away from the scale of the country’s losses.

“There will be a real urge to say, ‘See how well we’re doing,” said Nancy Bristow, chair of the history department at the University of Puget Sound in Tacoma, Wash. And author of American Pandemic: The Lost Worlds of the 1918 Influenza Epidemic. ”But she now warned of tendencies to“ rewrite this story into another story of American triumph ”.

Categories
Health

Covid vaccine shipments delayed by storm to reach by midweek: White Home advisor

Covid vaccine shipments delayed by storm to arrive by midweek: White House advisor

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are being prepared for shipment on December 13, 2020 at the Pfizer Global Supply Kalamazoo manufacturing facility in Portage, Michigan.

Morry Gash | Getty Images

All deliveries of Covid-19 vaccine doses delayed by the historic winter storm last week are expected to be delivered mid-week, Andy Slavitt, Senior White House Advisor for Covid-19 Response, said Monday.

Slavitt said Friday that shipments of about 6 million cans, equivalent to shipments worth about three days, were delayed by the storm.

“I reported on Friday that we would make up for the deliveries by the end of this week,” said Slavitt on Monday at the Covid-19 White House press conference. “We now assume that any remaining cans will be delivered by the middle of the week.”

He added that the federal government plans to ditch about 7 million vaccine doses on Monday, a combination of shots left behind from last week and some that should run out this week. He said the government’s ability to catch up quickly on the storm was thanks to members of the military and McKesson staff who the government hired to assist with distribution and logistics in getting the vaccine up and running.

“Seventy McKesson employees volunteered to work Saturday night and Sunday morning at 1am to prepare shipments for an 11am transit deadline,” he said, adding that UPS employees are also flexible on delayed deliveries could react.

Slavitt added that although the White House expected to catch up on the doses dispensed quickly, “it will take some time” for vaccination centers to catch up on vaccinations.

“We encourage vaccination centers to follow the same example of those who work longer hours to catch up on supplies by allowing more appointments to vaccinate the anxious public as soon as possible,” he said. Slavitt added that vaccination centers are still closed in some parts of the country that were particularly hard hit by the storm.

The pace of vaccination in Texas, rocked by the storm that left millions in the state without electricity, suffered badly. Slavitt said the 7-day average of daily doses received fell 31% over the past week.

Categories
Health

CDC research reveals academics might play ‘central position’ in Covid unfold at colleges

CDC study shows teachers could play 'central role' in Covid spread at schools

A student is seen walking down the steps of PS 139 closed public school in the Ditmas Park neighborhood of Brooklyn, New York, United States on October 8, 2020.

Michael Nagle | Xinhua News Agency | Getty Images

School teachers and staff could play a “central role” in the transmission of Covid-19 in schools that fail to follow social precautions and precautions against facial covering. Vaccination for the disease could help get students back to class safely, according to a new state study released Monday.

The U.S. Centers for Disease Control and Prevention studied the spread of the coronavirus in eight Georgia public elementary schools in the same school district between December 1 and January 22, including 24 days of face-to-face study. During that period, the average number of cases per 100,000 residents of the county increases by nearly 300%, the study said.

The Federal Health Office, together with the state and local health authorities, found nine Covid-19 “clusters” in which 13 educators and 32 pupils at six of the eight primary schools were involved.

The median cluster size – defined as three or more linked Covid-19 cases – was six people, and one educator was the “index patient” or the first case identified in four of these clusters, the CDC found. One student was the first patient in a cluster while the other four clusters had an unidentifiable index patient.

All but one of the clusters included “at least one educator and a likely educator-to-student transfer,” according to the study.

“These results suggest that educators can play an important role in transmission in school and that transmission in school can occur when physical distance and mask compliance are not optimal,” the CDC researchers wrote in the study.

In the study, CDC researchers said they conducted interviews with parents, educators, and school principals and examined seating plans, classroom layouts, physical distancing, and adherence to recommended mask use in face-to-face learning to identify case links.

They found that social distancing recommendations were “less than ideal” followed across all nine clusters. Students sat less than three feet apart, and in many cases the virus was able to spread among students, and students could have spread in small group sessions, according to the study.

The results come just over a week since the CDC released new guidance on how to safely reopen schools to face-to-face learning despite the spread of the virus. Among the numerous recommendations, the CDC advises districts to introduce their reopening plans according to the severity of the outbreak in their areas.

It also states that schools should adopt “essential elements” for resumption of personal learning, including wearing masks, physical distancing, and monitoring the level of spread in the surrounding community.

While the CDC advised states to give priority to vaccinating teachers and staff “as soon as supplies permit,” the guidelines did not recommend it for reopening. However, the study, published Monday, suggested that vaccinating educators could be important in protecting the most vulnerable while reducing disruptions to personal learning and potentially preventing the virus from spreading in schools.

“While COVID-19 vaccination is not required for schools to reopen, it should be viewed as an additional mitigation measure that should be added as it becomes available,” the researchers wrote.

– CNBC’s Will Feuer contributed to this report.

Categories
Health

Delays Flip Canada’s Covid Vaccination Optimism Into Nervousness

Delays Turn Canada’s Covid Vaccination Optimism Into Anxiety

OTTAWA – Canada seemed to be off to a quick start. Regulators had approved a coronavirus vaccine that Pfizer co-developed shortly before the United States, and national news broadcasts were soon filled with pictures of people receiving their first injections.

But hopes raised by the December vaccination launch – including news that Canada had ordered doses ten times its population – have worsened. Manufacturing issues at Pfizer and Moderna, makers of the two vaccines currently approved in Canada, have resulted in reduced shipments – including several weeks with no vaccine at all.

But while the disruption has become a talking point for the nation, more fundamental factors affecting Canada’s strategic decisions and manufacturing realities have always resulted in the launch of vaccinations being a test run rather than a full rollout.

Even if Canada is back on schedule, this nation is expected to receive just six million doses of 37.5 million people by the end of next month. So far, only about 1.5 million people have been injected.

Updates to a global vaccination ranking now get almost as much media coverage as hockey results. With the UK and even the United States continuing to climb the rankings despite their troubles, Canada has fallen significantly on the list that sits between Bangladesh and Romania this week.

The country’s vaccination fears have caused a drop in approval ratings for Prime Minister Justin Trudeau’s performance during the pandemic, according to polls. Almost 60 percent of Canadians believe the country should do better or at least as well as other developed nations, according to a survey.

It has also sometimes sparked fierce criticism from the conservative opposition in parliament and from several provincial premieres whose governments are responsible for putting needles in weapons.

“While the world is vaccinating millions of times, the government can only deliver a few thousand,” Conservative leader Erin O’Toole said in parliament on Tuesday. “Where’s the plan to get vaccines into the arms of Canadians?”

Mr. Trudeau acknowledged the impatience but tried to give assurances.

“People are worried, people are fed up with this pandemic,” he said at a press conference last week. “There is a lot of fear and there is a lot of noise right now. So I want to assure the Canadians that we are on the right track. “

Canada wasn’t alone. Short shipments of vaccines have also created tension in Europe and other parts of the world

The pressure on Mr. Trudeau could ease. After Pfizer slowed and temporarily suspended shipments to Canada while a factory in Belgium was rebuilt to increase production, Pfizer sent its largest vaccine shipment to Canada this week. However, part of this broadcast was delayed by storms en route across the United States.

While the prime minister said that Pfizer’s new shipments will allow Canada to hit its six million can target by the end of March, it still means the vast majority of Canadians will likely wait for their shots well into the summer becomes.

Vaccine and infection control specialists say Canada’s start has always been sluggish due to several key factors, most notably its decision last year to split its 414 million orders across seven different companies to reduce risk rather than upfront for a single vaccine put suppliers. To date, only two of these companies have approved vaccines for use in Canada.

Updated

Apr. 21, 2021, 6:38 p.m. ET

Canada also has inherent drawbacks: Most notably, its lack of an established vaccine manufacturer headquartered in the country and its relatively limited manufacturing capacity for making the vaccines developed by overseas companies.

Experts said the short or late deliveries shouldn’t have surprised anyone so far.

“There has never been a vaccine rollout that did not go into bottlenecks due to problems fixing manufacturing errors,” said Dr. Scott Halperin, Professor of Medicine at Dalhousie University in Halifax and Medical Director of the Canadian Center for Vaccination Science. “Anyone who didn’t anticipate hiccups in the manufacturing process just wasn’t aware of the past.”

Dr. David N. Fisman, professor of epidemiology at the University of Toronto’s Dalla Lana School of Public Health, attributed the national hand pressing to another factor.

“It looks more like we got what we expected with the occasional hiccup,” he said. “I think most of the sound and anger really just relates to the political scoring. Is there anything the federal government could realistically have done to get more vaccines earlier and magically stop those hiccups? “

Doug Ford, Ontario’s Conservative Prime Minister, suggested an answer despite his political viability. During a press conference last month, he called on President Biden to send Canada a million doses of vaccine from a Pfizer Michigan facility located within driving distance of the international border.

“Our American friends, help us,” said Mr Ford, who has avoided criticizing Mr Trudeau. “You have a new president, no more excuses.”

Under the Canadian system, the provinces are responsible for the operation of health systems, including administering vaccinations, while the federal government regulates vaccines and drugs and negotiates prices. With the pandemic, Mr. Trudeau also took responsibility for purchasing the country’s vaccine supply.

Brian Pallister, the Prime Minister of Manitoba, broke with that program last week, announcing that his province will be spending $ 36 million Canadian dollars to buy vaccines from a small business in Calgary, Alberta that is powered by the development of a vaccine for cancer has switched to the coronavirus.

“I just want a Canadian home advantage,” Pallister said as he urged other prime ministers to work with him to “work with him on a Canadian-made solution, not just for today but for tomorrow.”

However, the vaccine from Calgary Company, Providence Therapeutics, isn’t going to speed up vaccination rates anytime soon. The company, which has asked Mr Trudeau’s government for financial support, did not start the first phase of human trials of his vaccine until late January.

Assuming the vaccine is approved, Providence expects production to begin late this year or early next year – long after Mr Trudeau’s September goal of vaccinating all Canadians.

With Canada released little information about its vaccination contracts, Mahesh Nagarajan, a professor in the Sauder School of Business at the University of British Columbia in Vancouver, said it was impossible to see if anything could be done to expedite supplies.

Dr. However, Nagarajan said the country’s relatively small population and lack of membership in a trading bloc like the European Union put it in a comparatively weak negotiating position.

“When production is done elsewhere and resources are scarce, you can’t just assume that people will ship things,” said Dr. Nagarajan, adding that the province’s effectiveness in administering vaccines is likely to determine whether Mr Trudeau’s September target can be met.

Dr. Fisman said he was optimistic that Canada “will be inundated with vaccine supplies by the summer”. By then, he had some advice for Canadians.

“People need to take a few deep breaths and get through March and April,” he said. “I think we’re actually fine.”

Categories
Health

Fauci cautions towards complacency as Covid infections lower

Biden Covid team holds briefing after securing more vaccine doses

Dr. Anthony Fauci warned Americans on Sunday to fight back a sense of Covid-19 complacency even as coronavirus infections decline and some scientists predict that herd immunity is just around the corner.

“The slope that comes down is really great – it’s very steep and it goes down very, very quickly. But we’re still at a very high level,” Fauci, a top pandemic adviser to President Joe Biden, told NBC . Meet the press. “

Fauci said he didn’t want people to think “we’re out of the woods now” just because the surge in infections dropped sharply.

“We’re not. Because the baseline of daily infections is still very, very high,” said Fauci. “It’s not the 300,000 to 400,000 we had a while ago, but we really, really, really want to keep that baseline low before we start thinking we’re not in the woods.”

The pandemic, which first struck the nation early last year, has entered a new phase as the pace of vaccinations increases and the number of new infections decreases, even as the US is close to hitting the grim milestone of 500,000 Covid- 19- stand. related deaths.

The 7-day moving average of new infections was 71,717 on Saturday. As a CNBC analysis of Johns Hopkins University data, less than half of the 146,034 new daily infections reported earlier in the month, also a 7-day average.

More than 497,000 people have died of the disease in the United States since Sunday.

Fauci’s comments to host Chuck Todd came in response to an opinion piece published Thursday in the Wall Street Journal by Dr. Martin Makary, a surgeon at Johns Hopkins University, who predicted the country will reach herd immunity in April.

Makary wrote that his prediction was based on data and science, as well as anecdotal evidence. He said that some medical experts privately agreed with his out-of-consensus view but warned him not to discuss it lest he inadvertently encourage the public to become complacent, fail to take precautions, or not receive the vaccine.

“On the current path, I expect Covid will be largely gone by April, which will allow Americans to resume normal lives,” wrote Makary, saying that current estimates of natural immunity have likely been low.

Fauci said he was “not so sure” that the recent decline in infections was due to herd immunity or the phenomenon in which a critical number of people become resistant to the virus as a result of previous exposure or vaccination.

“Certainly the number of infected people contributes to this. Also a certain contribution with vaccines, not much,” said Fauci. “I think we haven’t vaccinated enough people yet to achieve herd immunity. I think you see nature peak and sink.”

Dr. Scott Gottlieb, the former head of the Food and Drug Administration, also spoke on Sunday, saying in an interview on CBS News’ Face the Nation that he expected the current decline in cases to continue.

Gottlieb said that if only 40% of the population have some form of immunity, the rate of infection can be slowed down significantly, a number lower than the 75% Fauci estimated to be the level for herd immunity.

In some parts of the country, Gottlieb added: “We just got that.”

“I think we should be optimistic. I think we will continue to see a fall in infection rates in the spring and summer,” he said.

The debate on the state and dynamics of the virus comes a year after the extended lockdowns and other preventive measures that stalled much of the economy, inflicted mental health trauma on a previously unknown number, and forced families apart.

Biden said achieving herd immunity could be a difficult task by the end of next summer that would force parents to grapple with the idea of ​​starting another school year in pandemic conditions.

Even if the country contains the virus significantly, it is possible that some measures to protect against its spread may continue. Fauci said on CNN Sunday that even if the country gets a certain level of normalcy, Americans may wear masks to prevent the spread of Covid-19 over the next year.

“It is possible that it will,” Fauci said of wearing masks in 2022. “It depends on the dynamics of the virus in the community. When you see the level is really, really, really low, I want it to be preserved. ” It comes to a baseline that is so low that … there is a minimal, minimal threat to someone who is infected. “

Biden’s cautious approach is a reverse of the abundant and sometimes ruthless optimism of his predecessor, former President Donald Trump. The measured remarks by the Biden government have sparked criticism from the opposite direction. Some say the government is setting targets that are too low given encouraging data.

The increase in the number of people receiving vaccinations has generated limited optimism. About 1.7 million vaccines are administered daily, up from the White House target of 1.5 million per day. Public health experts have said the rate could double by the end of the month if supply continues.

Despite these optimistic projections, major concerns remain about a number of new coronavirus mutations, some of which have been shown to be more transmissible than the dominant strain in the U.S. It is possible that mutant strains could prove resistant to the approved vaccines by experts, although experts have largely said that they expect the current vaccines to work.

A strain of particular concern, first identified in the UK, doubles its presence in the US every 10 days, according to a study published earlier this month.

While the study found the strain was circulating at low absolute levels, it helped model the Centers for Disease Control and Prevention, which predicted the strain known as B.1.1.7., The dominant strain in the U.S. for the next month could be .

Dr. Michael Osterholm, former advisor to the Biden transition team, said Jan. 31 that B.1.1.7 is likely to see an increase in “the next six to 14 weeks”.

“And when we see what my 45 years in the trenches tell me, we will see something we have never seen in this country,” warned Osterholm.

The CDC has identified three mutant strains in the United States that “have particularly affected the world’s public health and health care leaders,” including B.1.1.7 and variations first identified in South Africa and Japan. The variant identified in Japan was found on travelers from Brazil.

Gottlieb said the variants presented “some risk” but that there was already “enough protective immunity that we will likely see them.” [positive] Trends continue. “

The variations, he said, “will not be enough to reverse these trends at this point.”

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest during the next president’s term.

Categories
Health

What My Father’s Covid Survival Taught Me About Safety

What My Father’s Covid Survival Taught Me About Security

My father protects his livelihood but is by nature invisible. For more than two decades he watched the halls of a shopping mall in Koreatown, Los Angeles, as a security guard. The square is a three-story building with salmon-colored walls and a distinctive glass skylight. It is a community landmark for Korean immigrants who have survived financial insecurities, language barriers and other problems with uncharted territory in a strange place. In 1997 my father went there looking for a job. Our family had just arrived from the Philippines and he needed to anchor our landing on a steady income. As an electrician with no experience in safety work, he was immediately hired. Over time, he found purpose in securing his new life, family, and mall.

As a kid, I loved walking in the square to look at foreign goods that made me feel at home: copper bowls that can hold an ocean of stews, K-pop tunes on imported speakers, red bean cookies that bulge like clouds is. I loved to watch my father during his patrols. It was a rare glimpse into his full expression of himself temporarily unrelated to fatherhood. He chased shoplifters a few times a year. He once rescued a shopkeeper who suffered a concussion after a faulty metal grate fell on him while he was closing his booth. My father played peacemakers and tempered business rivalries he barely understood. But as he grew into his job, it made him small. He hardly earned a minimum wage. Buyers passed him, unaffected by his presence. As I got older, it hurt to see him as a silhouette of myself, faceless.

Like him, I took on a profession that was about safety, but there was a great gap between his and my work. I explored one of the most violent forms of destruction invented by human hands: nuclear weapons. I armed myself with the power of speeches and textbooks, political memos and conferences to convince governments to secure nuclear facilities and practice arms control. I envisioned my work to prevent a hypothetical terrorist from building a dirty bomb or an unpredictable politician from threatening nuclear war. Security became a complicated patchwork of policies and diplomatic agreements, all of which in theory would save them from nuclear annihilation. “Everyone” is vaguely defined, but it sounds impressive.

I felt my father’s pride in my career, but we lacked the language to express the depth of our working lives. Over the years we remained silent, convinced that if we talked we would pass each other. It never occurred to me to associate what I do with my father’s work or mine.